ARCHIVES

FDA Staff Efforts To Issue Warning Letters On Procrit Ads Were Stopped By Counsel.

This article is from The Cancer Letter archive.

Vol. 34 No. 18 | May 9, 2008

Download PDF Visit The Full Archive

Related Articles

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

December 3, 2010

DCT Advisors Approve $22 Mil. Set Aside For Interactive R01s Systemic Therapies

July 10, 1992

“We’re All Filling Up With Carcinogens” Ames Tells NCAB

October 7, 1977

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014

Clinical Trials Approved By NCI Last Month Are Listed

February 28, 2003

Bypass Budget Is Realistic, Defensible Plan, Broder Says

September 27, 1991